PTC Therapeutics | Nettoeinkommen

Aktienkurs
74.68
Täglich Wechseln
2.32 3.21%
Monatlich
-3.31%
Jährlich
50.96%
Q1 Prognose
72.39




Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Cytokinetics USD -306.18M 171.81M 2025-09
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Gilead Sciences USD 3.05B 1.09B 2025-09
Incyte USD 424.17M 19.17M 2025-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
TG Therapeutics USD 390.9M 362.71M 2025-09
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09
Xencor USD -6.03M 24.8M 2025-09


PTC Therapeutics Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.